''I mentioned this to you a few weeks ago. What if Kazia releases good trial data BEFORE any credit raise?
It's not a far fetched thought...it actually could happen. '
JohnnyBlue
IMO
Cantrixil is in phase 1
GDC0084 is in phase 11a - safety dosage stage - and many collaborations for phase 1 or 2 that will take years to complete
What great results can one expect at these stages ?
Completing a phase 1 or 2 trial for safety -efficacy is hardly a company changer - hence beyond this is where the significant capital will be required for this $23m market cap nano biotech...
- Forums
- ASX - By Stock
- KZA
- GDC--0084
GDC--0084, page-37
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)